Robert A. Bradway - Dec 2, 2024 Form 4 Insider Report for AMGEN INC (AMGN)

Role
Chairman, CEO and President, Director
Signature
/s/ Robert A. Bradway
Stock symbol
AMGN
Transactions as of
Dec 2, 2024
Transactions value $
$0
Form type
4
Date filed
12/3/2024, 07:48 PM
Previous filing
Oct 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMGN Common Stock Gift $0 -96K -14.33% $0.00 574K Dec 2, 2024 Direct F1
transaction AMGN Common Stock Gift $0 +90K $0.00 90K Dec 2, 2024 By Spousal GRAT F3
transaction AMGN Common Stock Gift $0 -90K -18.6% $0.00 394K Dec 2, 2024 Direct F3, F4
holding AMGN Common Stock 90K Dec 2, 2024 By GRAT F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were gifted by the reporting person and the reporting person's spouse to two irrevocable trusts for the benefit of the reporting person's children, subsequent to the same-day transfer by the reporting person of 48,000 shares as separate property of the reporting person's spouse. Neither the reporting person nor the reporting person's spouse are trustees of the children's trusts or otherwise have the power to vote or dispose of the assets held in such trusts.
F2 On 12/2/2024, the reporting person contributed 90,000 shares to the reporting person's grantor retained annuity trust of which the reporting person and the reporting person's spouse serve as trustees and the reporting person is the sole annuitant, resulting in indirect ownership by the reporting person of these shares.
F3 Subsequent to the same-day transfer by the reporting person of 90,000 shares as separate property of the reporting person's spouse, such shares were contributed to a spousal grantor retained annuity trust of which the reporting person and the reporting person's spouse serve as trustees and the reporting person's spouse is the sole annuitant, resulting in indirect ownership by the reporting person of these shares.
F4 Shares directly beneficially owned also include 2,141 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested restricted stock units (RSUs) and are paid out in shares of the Company's common stock on a one-to-one basis upon vesting of the associated RSUs with a cash payment for any remaining fractional share amount.